Interventional Center for Pain Management v. Director of Revenue

Summary

The Supreme Court of Missouri affirmed the Administrative Hearing Commission’s determination that the Center’s needle, syringe and related devices are not exempt from use tax under §144.054.2 because they are not used in the compounding of a marketable product. The Court applied a three‑part test and held the Center failed to meet the product requirement.